Literature DB >> 15061491

Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity.

M Mollerach1, M Regueira, L Bonofiglio, R Callejo, J Pace, J L Di Fabio, S Hollingshead, D Briles.   

Abstract

PspA is an antigenically variable virulence factor of Streptococcus pneumoniae that inhibits complement deposition and is a potential candidate for human vaccines. Of 64 published strains 96% are in PspA families 1 and 2; optimal protection is family-specific. Effective development of a PspA-containing vaccine requires more information about the PspA family of strains in parts of the world where the vaccine is most needed. In these studies we observed that of 149 isolates (of 19 capsular types) from Argentina, 54.4% were family 1, 41.6% were family 2 and 4.0% expressed both family 1 and family 2 PspAs. Box typing revealed the Argentinian strains to be from at least 10 clonally related groups.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061491      PMCID: PMC2870092          DOI: 10.1017/s0950268803001626

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil.

Authors:  Fabiana Cristina Pimenta; Fátima Ribeiro-Dias; Maria Cristina C Brandileone; Eliane N Miyaji; Luciana C C Leite; Ana Lúcia S Sgambatti de Andrade
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children.

Authors:  J Qian; K Yao; L Xue; G Xie; Y Zheng; C Wang; Y Shang; H Wang; L Wan; L Liu; C Li; W Ji; Y Wang; P Xu; S Yu; Y-W Tang; Y Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-04       Impact factor: 3.267

3.  Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Authors:  Christina M Croney; Moon H Nahm; Steven K Juhn; David E Briles; Marilyn J Crain
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

4.  Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.

Authors:  Dennis O Gor; Xuedong Ding; David E Briles; Michael R Jacobs; Neil S Greenspan
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland.

Authors:  Ewa Sadowy; Anna Skoczyñska; Janusz Fiett; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Clin Vaccine Immunol       Date:  2006-01

6.  Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

Authors:  M Darrieux; E N Miyaji; D M Ferreira; L M Lopes; A P Y Lopes; B Ren; D E Briles; S K Hollingshead; L C C Leite
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

7.  Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.

Authors:  Martina M Ochs; William Bartlett; David E Briles; Bryony Hicks; Audra Jurkuvenas; Peggy Lau; Bing Ren; Amanda Millar
Journal:  Microb Pathog       Date:  2007-10-11       Impact factor: 3.738

8.  Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan.

Authors:  Y Ito; M Osawa; R Isozumi; S Imai; I Ito; T Hirai; T Ishida; S Ichiyama; M Mishima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

9.  Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Authors:  Il Gyu Kong; Ayuko Sato; Yoshikazu Yuki; Tomonori Nochi; Haruko Takahashi; Shinichi Sawada; Mio Mejima; Shiho Kurokawa; Kazunari Okada; Shintaro Sato; David E Briles; Jun Kunisawa; Yusuke Inoue; Masafumi Yamamoto; Kazunari Akiyoshi; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

10.  Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.

Authors:  Marcela Medina; Julio Villena; Elisa Vintiñi; Elvira María Hebert; Raúl Raya; Susana Alvarez
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.